GNA11 and neoplasm: We did not consider EIF1AX mutations since they are not associated with metastatic risk likely co-driving tumor initiation but not progression and we also excluded GNA11 as a risk factor which, in comparison to the other risk factors, only contributes a minor risk elevation [12].